BCA
CELU icon

Bray Capital Advisors’s Celularity CELU Stock Holding History

Bray Capital Advisors’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$208 Hold
100
– – ﹤0.01% 256
2024
Q3 		$297 Hold
100
– – ﹤0.01% 258
2024
Q2 		$313 Hold
100
– – ﹤0.01% 255
2024
Q1 		$523 Hold
100
– – ﹤0.01% 259
2023
Q4 		$247 Hold
100
– – ﹤0.01% 258
2023
Q3 		$222 Hold
100
– – ﹤0.01% 255
2023
Q2 		$533 Hold
100
– – ﹤0.01% 256
2023
Q1 		$620 Hold
100
– – ﹤0.01% 263
2022
Q4 		$1.29K Hold
100
– – ﹤0.01% 260
2022
Q3 		$2K Hold
100
– – ﹤0.01% 278
2022
Q2 		$3K Hold
100
– – ﹤0.01% 261
2022
Q1 		$9K Buy
+100
New +$5.99K ﹤0.01% 251

Other funds holding CELU

CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KFS
Keynote Financial Services Vernon, Connecticut $188M AUM 31.85% 1-Year Est. Return

Bray Capital Advisors's CELU Position: Q4 2024 in Review

Bray Capital Advisors held its Celularity (CELU) position steady in Q4 2024 at 100 shares worth $208. The position accounts for ﹤0.01% of the portfolio, ranked #256.

Bray Capital Advisors first reported a position in CELU in Q1 2022 and has held it in 12 quarters since. The position peaked at $9K in Q1 2022. 32 funds tracked by Wall St. Rank hold CELU as of Q4 2024.

  • Bray Capital Advisors held 100 shares of Celularity worth $208 as of Q4 2024.
  • Bray Capital Advisors left its Celularity share count unchanged in Q4 2024.
  • Celularity made up ﹤0.01% of Bray Capital Advisors's portfolio in Q4 2024, its #256 holding.
  • Bray Capital Advisors first reported a position in Celularity in Q1 2022 and has held it in 12 quarters since.
  • Bray Capital Advisors's Celularity position peaked at $9K in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Celularity as of Q4 2024.

Based on Bray Capital Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.